Clinical Trials for Peritoneal Metastases and Emerging Trends Session

Oral Abstract Presenter(s)

• 

  Brian Badgwell, MD, MS

  Professor
  MD Anderson, Texas
• 

  Laura Lambert, MD

  Director, Peritoneal Malignancy Program
  Huntsman Cancer Institute, University of Utah
• 

  James McDonald, MD

  Surgical Oncology Research Fellow
  NIH / Surgical Oncology Program
• 

  Hironori Yamaguchi, MD, PhD

  Professor
  Jichi Medical University
  Shiotsuke, Japan

Speaker(s)

• JF

  Jason Foster, MD

  Associate Professor of Surgery
  University of Nebraska Medical Center
  Omaha, Nebraska, United States

Presentations:

• 10:30 AM – 10:45 AM

  Phase I Trial of Intraperitoneal Oxaliplatin in Combination with Intravenous FOLFIRI for Unresectable Peritoneal Carcinomatosis from Colorectal and Appendiceal Cancer
  Laura Lambert, MD – Huntsman Cancer Institute, University of Utah
• 10:45 AM – 11:00 AM

  A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology
  Brian Badgwell, MD, MS – MD Anderson
• 11:00 AM – 11:15 AM

  Long-Term Normothermic Intraperitoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastasis: Results from Clinical Trials Over a Decade in Japan
  Hironori Yamaguchi, MD, PhD – Jichi Medical University
• 11:15 AM – 11:30 AM

  Is There Benefit from Hyperthermic Intraperitoneal Chemotherapy in Advanced Gastric Cancer: Early Results from a Phase II Clinical Trial
  James D. McDonald, MD – NIH / Surgical Oncology Program
• 11:30 AM – 11:45 AM

  Update: CRS versus CRS/HIPEC in Colon Cancer Peritoneal Metastases
  Jason Foster, MD – University of Nebraska Medical Center